Biotechnological applications of Bacillus licheniformis. (19th May 2021)

• Record Type: Journal Article
• Authors: Muras, Andrea; Romero, Manuel; Mayer, Celia; Otero, Ana
• Is Part Of: Critical reviews in biotechnology. Volume 41:Number 4(2021)
• Page Start: 609
• Page End: 627
• Publication Date: 2021-05-19
• Subjects: Bacillus licheniformis -- industry -- probiotics -- expression platform -- bioremediation -- enzymes; Biotechnology -- Periodicals; Biotechnology -- Periodicals; Review Literature -- Periodicals; Public Health -- Periodicals; Environment -- Periodicals; Industry -- Periodicals; Biotechnology; Review Literature; Public Health; Environment; Industry; 660.6
• DOI: 10.1080/07388551.2021.1873239
• Languages: English
• ISSNs: 0738-8551

Abstract

Abstract: Bacillus licheniformis is a Gram positive spore-forming bacterial species of high biotechnological interest with numerous present and potential uses, including the production of bioactive compounds that are applied in a wide range of fields, such as aquaculture, agriculture, food, biomedicine, and pharmaceutical industries. Its use as an expression vector for the production of enzymes and other bioproducts is also gaining interest due to the availability of novel genetic manipulation tools. Furthermore, besides its widespread use as a probiotic, other biotechnological applications of B. licheniformis strains include: bioflocculation, biomineralization, biofuel production, bioremediation, and anti-biofilm activity. Although authorities have approved the use of B. licheniformis as a feed additive worldwide due to the absence of toxigenic potential, some probiotics containing this bacterium are considered unsafe due to the possible transference of antibiotic resistance genes. The wide variability in biological activities and genetic characteristics of this species makes it necessary to establish an exact protocol for describing the novel strains, in order to evaluate its biotechnological potential.